Mechanism of Action and Pharmacological Effects
This medication belongs to the para-aminophenol derivative class. It exerts its biological activity through a selective mechanism of action. Its primary target is the cyclooxygenase (COX) enzyme; however, inhibition does not occur in peripheral tissues, but predominantly within the central nervous system (CNS). Additionally, it is hypothesized that the serotonergic and endocannabinoid systems of the brain contribute to its central analgesic effects.
Due to this specific distribution of activity, the drug produces two key pharmacological effects:
- Analgesic: Effectively interrupts the transmission of pain impulses.
- Antipyretic: Acts on the hypothalamic thermoregulation center to reduce elevated body temperature.
Note: The drug lacks anti-inflammatory activity entirely, setting it apart from traditional NSAIDs.
Clinical Application
In medical practice, the drug is used exclusively for symptomatic therapy. Regarding its analgesic and antipyretic efficacy, it is fully comparable to aspirin.
Primary indications include:
- Relief of mild to moderate pain (headache, arthralgia, neuralgia, myalgia).
- Reduction of fever of various origins.
Note: It is frequently used as a first-line antipyretic in pediatric populations due to a favorable gastrointestinal safety profile compared to NSAIDs.
Toxicology and Narrow Therapeutic Index
When recommended therapeutic doses are observed, side effects are extremely rare, and the drug is well tolerated. However, its major pharmacological limitation is its narrow therapeutic index.
The toxic dose exceeds the standard therapeutic dose by only threefold. Overdose leads to a life-threatening hepatotoxic effect characterized by extensive centrilobular hepatocyte necrosis. The mechanism of this toxicity stems from the depletion of hepatic glutathione stores and the consequent accumulation of a highly reactive, toxic metabolite: N-acetyl-p-benzoquinone imine (NAPQI).
Antidote Therapy for Overdose
In cases of overdose and impending liver failure, emergency medical intervention is required. Specific antidote therapy relies on the administration of sulfhydryl group donors.
Rescue agents include:
- Acetylcysteine
- Methionine
A critically important factor for success is time. Antidotes must be administered within the first 8–12 hours following ingestion to neutralize the toxic metabolite before irreversible hepatic necrosis occurs.